Drug Clinical Trials List

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
A Phase 4, Multicenter, Multi-Country, Open-Label, Single-Arm Study to Investigate the Effectiveness and Safety of Tirzepatide Once Weekly in Adult Participants with Type 2 Diabetes during Ramadan (T-RAM)	Eli Lilly	Ongoing	Tirzepatide	4	I8F-MC-GPIY	Al Moosa Specialized Hospital (al ahsa), King Faisal Specialist Hospital and Research Center (Riyadh), Saudi Airlines Medical Service Center (Jeddah), King Fahad Medical City (Riyadh), Dallah Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah), King Faisal Specialist Hospital and Research Center (Madinah)
A Phase 3, Randomized, Double-blind, Placebo-controlled, Cross over Study of Oral Deucrictibant Soft Capsule for On Demand Treatment of Attacks in Adolescents and Adults with Hereditary Angioedema	Pharvaris Netherlands B.V.	Ongoing	Deucrictibant	3	PHA022121-C306	King Faisal Specialist Hospital and Research Center (Riyadh)
A Phase 3 Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)	Janssen Research & Development	Ongoing	Nipocalimab	3	80202135EBF3001	King Faisal Specialist Hospital and Research Center (Riyadh), King Saud Medical City (Riyadh), King Fahad University Hospital (Al-Khobar)
Evaluating the efficacy and safety of Brentuximab Vedotin + AVD (Adriamycin, Vinblastine & Dacarbazine) in Newly Diagnosed Advanced Hodgkin Lymphoma Early Interim PET-Positive Patients; A Multi-Center, Open Label, Single Arm, Phase II, PET-Adaptive Study	King Abdullah International Medical Research Center’s (KAIMRC)	Ongoing	Brentuximab Vedotin + AVD (Adriamycin, Vinblastine & Dacarbazine	2	RJ19/119/J	King Abdullah Medical Complex (Jeddah)
A Randomized Controlled Trial Comparing Blood Glucose Control Intraoperative Between Insulin Drip vs. Insulin Boluses	King Faisal Specialist Hospital and Research Center (Jeddah)	Ongoing	Insulin	3	2023-45	King Faisal Specialist Hospital and Research Center (Jeddah)
The ENERGY 3 Study: A Randomized, Controlled, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of INZ-701 in Children with Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Deficiency	Inozyme Pharma, Inc	Ongoing	INZ701	3	INZ701-106	King Faisal Specialist Hospital and Research Center (Riyadh)
Long-term pain and adherence observational study for Endometriosis treatment	Abbott	Ongoing	Duphaston	4	DYDR-522-0318	Dr.Arab Clinic
Real world Assessment of Dyslipidemia patients on Inclisiran effiCacy And toLerability: The RADICAL Study	Novartis	Ongoing	LEQVIO	4	CKJX839A1S	Dallah Hospital (Riyadh),International Medical Center (Jeddah), Armed Force Hospital (Tabuk) , My Clinic (Jeddah) Mouwasat Hospital (Dammam)
Effect of celecoxib on postoperative narcotic use and disease severity in patients with aspirin-exacerbated respiratory disease and chronic rhinosinusitis: a randomized controlled trial	King Khalid University Hospital	Ongoing	Celecoxib	4	114809	King Khalid University Hospital (Riyadh) King Abdulaziz University Hospital (Riyadh)
EASi-HF - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral BI 690517 and empagliflozin compared with placebo and empagliflozin in participants with symptomatic heart failure (HF: NYHA II-IV) and left ventricular ejection fraction (LVEF) >40%	Boehringer Ingelheim	Ongoing	BI 690517 , empagliflozin	3	1378-0020	1-King Fahad Medical City (Riyadh) 2-King Khalid University Hospital (Riyadh) 3-King Faisal Specialist Hospital and Research Center (Riyadh) 4-King Abdulaziz Medical City NG (Riyadh) 5-King Abdulaziz University Hospital (Jeddah)